More than 1,000 participants received free screenings for blood pressure, cholesterol, triglycerides, body mass index, and peripheral vascular disease at heart-health fairs sponsored by the Mount Sinai Health System on Friday, February 6, National Go Red for Women Day. Read more
The New York State Department of Health recently awarded The Mount Sinai Hospital’s Cardiac Catheterization (Cath) Laboratory the highest “two-star” safety rating for percutaneous coronary interventions (PCI) in overall and nonemergency cases. This marks the 16th consecutive year that the Cath Lab, or one of its physicians, has received this prestigious two-star rating for safety when performing PCI. The minimally invasive procedure, also known as angioplasty, is used to diagnose and treat patients with heart disease or blocked arteries.
The Mount Sinai Hospital Cardiac Care Unit (CCU) was awarded a 2014 Beacon Award for Excellence from the American Association of Critical-Care Nurses (AACN), the leading society of acute- and critical-care nurses.
The Mount Sinai Hospital is one of three institutions in New York State, and one of one hundred in the nation, selected to study the safety and effectiveness of an implantable cranial nerve stimulation device for heart failure patients with debilitating fatigue, shortness of breath, and heart arrhythmias.